Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Sabine Brookman‐May, Matthias May et al.|PLoS ONE|2017Cited by 43
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patientsHendrik Borgmann, Sabine Brookman‐May, Mireía Musquera et al.|World Journal of Urology|2017Cited by 27
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyNikhil Vasdev, Peter C. Black, Homayoun Zargar et al.|World Journal of Urology|2018Cited by 9
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)Matthias May, Sabine Brookman‐May, C. Surcel et al.|Scandinavian Journal of Urology|2017Cited by 5
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: Results of an international multi-institutional study on 2189 patientsAnna Scavuzzo, S. Brookman-May, Ingmar Wolff et al.|European Urology Supplements|2017Cited by 1